Newsroom

[custom-facebook-feed feed=1]

DermaSensor Announces Publication of Positive Results from Clinical Validation Study of Skin Cancer Detection Device

MIAMI, FLORIDA, USA, July 7, 2022 /EINPresswire.com/ — DermaSensor Inc., a health technology company designing non-invasive tools to better equip primary care physicians (PCPs) to detect skin cancer, today announces the PATIENT-SELECT study results at the American Dermoscopy …

DermaSensor Announces Publication of Positive Results from Clinical Validation Study of Skin Cancer Detection Device Read More »

Company Successfully Completes First Ever FDA Pivotal Study for Skin Cancer Detection Device for Primary Care

MIAMI, FLORIDA, UNITED STATES, June 15, 2022 /EINPresswire.com/ Miami-Based DermaSensor, Inc. Raises Additional $10 Million To Prepare for U.S. Launch DermaSensor Inc., a health technology company designing non-invasive tools to better equip primary care physicians (PCPs) …

Company Successfully Completes First Ever FDA Pivotal Study for Skin Cancer Detection Device for Primary Care Read More »

DermaSensor, Inc Announces Positive Results From Melanoma Clinical Validation Study of Skin Cancer Detection Device

DermaSensor’s optical spectroscopy and artificial intelligence technology demonstrated a 96% melanoma detection rate and a Negative Predictive Value of 98%. MIAMI, FL, U.S.A., March 29, 2022 /EINPresswire.com/ — DermaSensor Inc., a health technology company designing …

DermaSensor, Inc Announces Positive Results From Melanoma Clinical Validation Study of Skin Cancer Detection Device Read More »

Scroll to Top